• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化感染控制:实施障碍及改进思路。

Infection control in cystic fibrosis: barriers to implementation and ideas for improvement.

机构信息

Division of Infectious Diseases, Department of Pediatrics, Columbia University, New York, NY 10032, USA.

出版信息

Curr Opin Pulm Med. 2009 Nov;15(6):626-31. doi: 10.1097/MCP.0b013e328330d974.

DOI:10.1097/MCP.0b013e328330d974
PMID:19644375
Abstract

PURPOSE OF REVIEW

This review will focus on recent research documenting baseline adherence to infection control recommendations and barriers to their implementation as experienced by multidisciplinary cystic fibrosis (CF) care providers. In addition, controversies regarding optimal infection control will be discussed. Finally, suggestions to improve infection control in CF will be proposed.

RECENT FINDINGS

Compliance with recent guidelines was assessed for clinical microbiology laboratories and for infection control policies at CF care centers in the United States. Unlike earlier reports, the vast majority of laboratories used selective media for Burkholderia cepacia complex and identified all species of nonlactose fermenting Gram-negative bacilli. Fewer used selective media for Staphylococcus aureus or used agar-based susceptibility testing assays for Pseudomonas aeruginosa. Only 103 (65%) of 158 CF care centers provided written infection control policies for review and these were more likely to address inpatient than outpatient settings. Surveys of healthcare professionals showed that access to a copy of the CF infection control guidelines reduced barriers to adherence to selected infection control practices.

SUMMARY

These data suggest that access to national infection control guidelines and written local policies are critically important to improving infection control for CF.

摘要

目的综述

本篇综述将聚焦于最近的研究,记录多学科囊性纤维化(CF)护理提供者在遵循感染控制建议方面的基线依从性和实施过程中的障碍。此外,还将讨论关于最佳感染控制的争议。最后,将提出改善 CF 感染控制的建议。

最近的发现

对美国 CF 护理中心的临床微生物学实验室和感染控制政策进行了最近指南的依从性评估。与早期报告不同,绝大多数实验室使用选择性培养基来分离洋葱伯克霍尔德菌复合体,并鉴定所有非乳糖发酵革兰氏阴性杆菌。使用选择性培养基来分离金黄色葡萄球菌或使用琼脂基础药敏试验来分离铜绿假单胞菌的则较少。只有 158 个 CF 护理中心中的 103 个(65%)提供了书面感染控制政策供审查,而且这些政策更可能涉及住院患者而非门诊患者。对医疗保健专业人员的调查表明,获得 CF 感染控制指南的副本可以减少对某些感染控制措施的依从性障碍。

总结

这些数据表明,获得国家感染控制指南和书面的本地政策对于改善 CF 的感染控制至关重要。

相似文献

1
Infection control in cystic fibrosis: barriers to implementation and ideas for improvement.囊性纤维化感染控制:实施障碍及改进思路。
Curr Opin Pulm Med. 2009 Nov;15(6):626-31. doi: 10.1097/MCP.0b013e328330d974.
2
Survey of infection control policies for patients with cystic fibrosis in the United States.美国囊性纤维化患者感染控制政策调查。
Am J Infect Control. 2008 Apr;36(3):220-2. doi: 10.1016/j.ajic.2007.05.009.
3
Implementation of European standards of care for cystic fibrosis--control and treatment of infection.欧洲囊性纤维化护理标准的实施——感染的控制与治疗
J Cyst Fibros. 2009 May;8(3):211-7. doi: 10.1016/j.jcf.2009.03.001. Epub 2009 Apr 16.
4
Barriers to adherence to cystic fibrosis infection control guidelines.遵守囊性纤维化感染控制指南的障碍。
Pediatr Pulmonol. 2008 Sep;43(9):900-7. doi: 10.1002/ppul.20876.
5
Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families.囊性纤维化患者及其家属的感染控制知识、态度和实践。
Pediatr Pulmonol. 2012 Feb;47(2):144-52. doi: 10.1002/ppul.21528. Epub 2011 Aug 24.
6
Current infection control practices used in Australian and New Zealand cystic fibrosis centers.澳大利亚和新西兰囊性纤维化中心当前使用的感染控制措施。
BMC Pulm Med. 2020 Jan 17;20(1):16. doi: 10.1186/s12890-020-1052-y.
7
Adherence to the 2007 cystic fibrosis pulmonary guidelines: a national survey of CF care centers.对 2007 年囊性纤维化肺病指南的遵循情况:对 CF 护理中心的全国性调查。
Pediatr Pulmonol. 2012 May;47(5):434-40. doi: 10.1002/ppul.21573. Epub 2012 Jan 3.
8
Implementation of European standards of care for cystic fibrosis - provision of care.实施欧洲囊性纤维化护理标准——提供护理。
J Cyst Fibros. 2009 Sep;8(5):348-55. doi: 10.1016/j.jcf.2009.05.004. Epub 2009 Aug 22.
9
Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.美国临床微生物学实验室对处理囊性纤维化患者呼吸道标本的当前建议的依从性。
J Clin Microbiol. 2006 Apr;44(4):1547-9. doi: 10.1128/JCM.44.4.1547-1549.2006.
10
Surveying Cystic Fibrosis Care Centers to Assess Adoption of Infection Prevention and Control Recommendations.调查囊性纤维化护理中心,以评估感染预防和控制建议的采纳情况。
Infect Control Hosp Epidemiol. 2018 Jun;39(6):647-651. doi: 10.1017/ice.2018.72. Epub 2018 Apr 15.

引用本文的文献

1
Genome-wide association study of susceptibility to infection in cystic fibrosis.全基因组关联研究易感性感染在囊性纤维化。
Eur Respir J. 2024 Nov 7;64(5). doi: 10.1183/13993003.00062-2024. Print 2024 Nov.
2
Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa.感染性流行铜绿假单胞菌的囊性纤维化患者的感染控制知识、信念和行为
BMC Pulm Med. 2015 Nov 5;15:138. doi: 10.1186/s12890-015-0116-x.
3
Development of an inhaled dry-powder formulation of tobramycin using PulmoSphere™ technology.
采用 PulmoSphere™ 技术研制妥布霉素吸入干粉制剂。
J Aerosol Med Pulm Drug Deliv. 2011 Aug;24(4):175-82. doi: 10.1089/jamp.2010.0855. Epub 2011 Mar 11.
4
Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions.亚硝酸钠介导的在厌氧浮游和生物膜条件下杀死主要囊性纤维化病原体铜绿假单胞菌、金黄色葡萄球菌和洋葱伯克霍尔德菌。
Antimicrob Agents Chemother. 2010 Nov;54(11):4671-7. doi: 10.1128/AAC.00379-10. Epub 2010 Aug 9.